RT Journal Article
T1 Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology.
A1 Mizia-Stec, Katarzyna
A1 Caforio, Alida L P
A1 Charron, Philippe
A1 Gimeno, Juan R
A1 Elliott, Perry
A1 Kaski, Juan Pablo
A1 Maggioni, Aldo P
A1 Tavazzi, Luigi
A1 Rigopoulos, Angelos G
A1 Laroche, Cecile
A1 Frigy, Attila
A1 Zachara, Elisabetta
A1 Pena-Pena, Maria Luisa
A1 Olusegun-Joseph, Akinsanya
A1 Pinto, Yigal
A1 Sala, Simone
A1 Drago, Fabrizio
A1 Blagova, Olga
A1 Reznik, Elena
A1 Tendera, Michał
K1 Anticoagulation
K1 Arrhythmogenic right ventricular cardiomyopathy
K1 Atrial fibrillation
K1 Dilated cardiomyopathy
K1 Hypertrophic cardiomyopathy
K1 Restrictive cardiomyopathy
AB Cardiomyopathies are a heterogeneous group of disorders that increase the risk for atrial fibrillation (AF). The aim of the study is to assess the prevalence of AF, anticoagulation management, and risk of stroke/transient ischaemic attack (TIA) in patients with cardiomyopathy. Three thousand two hundred eight consecutive adult patients with cardiomyopathy (34.9% female; median age: 55.0 years) were prospectively enrolled as part of the EURObservational Research Programme Cardiomyopathy/Myocarditis Registry. At baseline, 903 (28.2%) patients had AF (29.4% dilated, 27.5% hypertrophic, 51.5% restrictive, and 14.7% arrhythmogenic right ventricular cardiomyopathy, P  The study reveals a high prevalence and diverse distribution of AF in patients with cardiomyopathies, inadequate anticoagulation regimen, and high risk of stroke/TIA in this population.
YR 2020
FD 2020-09-17
LK http://hdl.handle.net/10668/16268
UL http://hdl.handle.net/10668/16268
LA en
DS RISalud
RD Apr 5, 2025